Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Septic Arthritis: later-stage trial registry

3 of 7 indexed Septic Arthritis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Septic Arthritis: 7 US clinical trials tracked, 3 recruiting.

Septic Arthritis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Infectious Diseases Physicians, running 1 of these trials.

Enrollment posture brief

Registry condition septic-arthritis

OPEN 3 | RECR 43% | LATE 2 | EARLY 1 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Septic Arthritis (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Septic Arthritis

Septic Arthritis lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Septic Arthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Septic Arthritis is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Septic Arthritis trials is spread across many organizations.

    Infectious Diseases Physicians accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Septic Arthritis enrolment sits around 76 participants.

    Median target enrolment is 76 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Septic Arthritis research is mostly interventional.

    5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 42

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 2

Named interventions

Most-linked intervention names on Septic Arthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

anti-mycoplasma hominis antibodies Biological
1 trials
Salto Talaris Ankle Device
1 trials
Trimethoprim Sulfamethoxazole Drug
1 trials
Unrelated videos Other
1 trials
RETAIN Other
1 trials
Synovial Staphylococcus spp antigen panel Diagnostic test
1 trials
Synovial C-reactive Protein (CRP) Diagnostic test
1 trials
Synovial lactate assay Diagnostic test
1 trials

US sites by state

Facility locations filed on Septic Arthritis trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Wisconsin 1 trials
Virginia 1 trials
Texas 1 trials
Tennessee 1 trials
New York 1 trials
Indiana 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Septic Arthritis page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Septic Arthritis condition card totals 7 registered trials; most-linked intervention anti-mycoplasma hominis antibodies; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.